GW Pharmaceuticals plc (GWPH) Soars: Stock Up 13.9% - Tale of the Tape
24 April 2014 - 10:51PM
Zacks
GW Pharmaceuticals
plc (GWPH) was a big mover last session, as its shares
rose nearly 14% on the day. The rise came on solid volume too with
far more shares changing hands than in a normal session. This
breaks the trend for the company since Apr 3, as the stock is now
trading above the volatile price range of $44.00 to $60.86.
In the last 30 days, the company has not seen any estimate revision
and the Zacks Consensus Estimate also remained unchanged. However,
yesterday’s price action is encouraging, so make sure to keep a
close watch on this firm in the near future.
GW Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its
Earnings ESP is 0.00%.
Better-ranked medical stocks include Edwards Lifesciences
Corp. (EW), Enzymotec Ltd. (ENZY) and
Venaxis, Inc. (APPY). While Edwards Lifesciences
and Venaxis carry a Zacks Rank #2 (Buy), Enzymotec sports a Zacks
Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
VENAXIS INC (APPY): Get Free Report
ENZYMOTEC LTD (ENZY): Free Stock Analysis Report
EDWARDS LIFESCI (EW): Free Stock Analysis Report
GW PHARMA-ADR (GWPH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2024 to Aug 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More ENZYMOTEC LTD. News Articles